Celldex Therapeutics
CLDX
CLDX
178 hedge funds and large institutions have $1.83B invested in Celldex Therapeutics in 2025 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 56 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less funds holding
Funds holding: 180 → 178 (-2)
2.43% less ownership
Funds ownership: 108.93% → 106.51% (-2.4%)
53% less call options, than puts
Call options by funds: $3M | Put options by funds: $6.44M
Holders
178
Holding in Top 10
3
Calls
$3M
Puts
$6.44M
Top Buyers
| 1 | +$28.3M | |
| 2 | +$15.3M | |
| 3 | +$14.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$13M |
| 5 |
Millennium Management
New York
|
+$12.9M |
Top Sellers
| 1 | -$37.1M | |
| 2 | -$33.7M | |
| 3 | -$14.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.3M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$12.2M |
